Alison S. Long - 01 Nov 2023 Form 3 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Issuer symbol
TSHA
Transactions as of
01 Nov 2023
Net transactions value
$0
Form type
3
Filing time
03 Nov 2023, 16:40:06 UTC
Previous filing
18 Jan 2022
Next filing
31 May 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit List - Power of Attorney